Thermo Fisher Scientific Inc. Financial Report: Debt Insights & Strategies Revealed

$TMO
Form 8-K
Filed on: 2025-02-19
Source
Thermo Fisher Scientific Inc. Financial Report: Debt Insights & Strategies Revealed

Based on the extracted XML data from the financial report regarding Thermo Fisher Scientific Inc., here are the key insights and important information:

Company Overview

  • Entity Name: Thermo Fisher Scientific Inc.
  • CIK: 0000097745
  • Address: 168 Third Avenue, Waltham, MA 02451
  • Contact: 781-622-1000
  • Common Stock: Par value of $1.00
  • Stock Symbol: TMO
  • Exchange: NYSE

Debt Instruments

Thermo Fisher has several debt instruments listed with their respective due dates:

  1. 0.125% Notes - Due 2025
  2. 2.000% Notes - Due 2025
  3. 3.200% Notes - Due 2026
  4. 1.400% Notes - Due 2026
  5. 1.450% Senior Notes - Due 2027
  6. 1.750% Senior Notes - Due 2027
  7. 0.500% Notes - Due 2028
  8. 1.375% Notes - Due 2028
  9. 1.950% Notes - Due 2029
  10. 0.875% Notes - Due 2031
  11. 2.375% Notes - Due 2032
  12. 3.650% Notes - Due 2034
  13. 2.875% Notes - Due 2037
  14. 1.500% Notes - Due 2039
  15. 1.875% Notes - Due 2049

Reporting Date

  • Filing Date: February 19, 2025
  • Period Covered: The report encompasses financial information effective as of February 19, 2025.

Additional Context

  • The report includes various segments and stock classes, specifically noting different classes of stock and senior notes with explicit member dimensions for US GAAP (Generally Accepted Accounting Principles).

Insights

  • The company has a structured debt maturity profile with various notes due from 2025 to 2049, indicating a long-term financing strategy.
  • The interest rates on the notes range from 0.125% to 3.650%, reflecting a mix of low to moderate interest cost for the company.
  • The presence of multiple debt instruments suggests a diversification in funding sources, potentially reducing refinancing risk.

This information is crucial for investors and stakeholders analyzing the company's financial health, capital structure, and future obligations.